An Eight-week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Generalized Anxiety Disorder

PHASE2CompletedINTERVENTIONAL

Enrollment

325

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions

Anxiety Disorders

Interventions

DRUG

SSR149415

Oral administration (capsules of 50 and 100 mg)

DRUG

Placebo

Oral administration (capsules)

DRUG

Paroxetine

Oral administration (capsules)

Trial Locations (1)

Sanofi-Aventis Administrative Office, Bridgewater